Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
The assessment by doctors of the effectiveness of drugs.

The Journal of the Royal College of General Practitioners

Mapes RE, Williams WO.
PMID: 1011206
J R Coll Gen Pract. 1976 Dec;26(173):880-2.
Free PMC Article

There was no significant difference between the assessments by two groups of randomly-selected general practitioners on the effectiveness of the drug treatment for 19 common clinical conditions. The treatment of simple iron deficiency anaemia was considered the most effective...

Cite
Mapes RE, Williams WO. The assessment by doctors of the effectiveness of drugs. J R Coll Gen Pract. 1976;26(173):880-2
Mapes, R. E., & Williams, W. O. (1976). The assessment by doctors of the effectiveness of drugs. The Journal of the Royal College of General Practitioners, 26(173), 880-2.
Mapes, R E, and Williams, W O. "The assessment by doctors of the effectiveness of drugs." The Journal of the Royal College of General Practitioners vol. 26,173 (1976): 880-2.
Mapes RE, Williams WO. The assessment by doctors of the effectiveness of drugs. J R Coll Gen Pract. 1976 Dec;26(173):880-2. PMID: 1011206; PMCID: PMC2158434.
Copy Download .nbib Format: NLM
Practitioners' obligation: to the public or the drug industry?.

DICP : the annals of pharmacotherapy

Sarkar PK, Das SK.
PMID: 2728509
DICP. 1989 Feb;23(2):175-6. doi: 10.1177/106002808902300215.

No abstract available.

Cite
Sarkar PK, Das SK. Practitioners' obligation: to the public or the drug industry?. DICP. 1989;23(2):175-6doi: 10.1177/106002808902300215.
Sarkar, P. K., & Das, S. K. (1989). Practitioners' obligation: to the public or the drug industry?. DICP : the annals of pharmacotherapy, 23(2), 175-6. https://doi.org/10.1177/106002808902300215
Sarkar, P K, and Das, S K. "Practitioners' obligation: to the public or the drug industry?." DICP : the annals of pharmacotherapy vol. 23,2 (1989): 175-6. doi: https://doi.org/10.1177/106002808902300215
Sarkar PK, Das SK. Practitioners' obligation: to the public or the drug industry?. DICP. 1989 Feb;23(2):175-6. doi: 10.1177/106002808902300215. PMID: 2728509.
Copy Download .nbib Format: NLM
A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model.

DICP : the annals of pharmacotherapy

Raisch DW.
PMID: 2188440
DICP. 1990 May;24(5):537-42. doi: 10.1177/106002809002400514.

The purpose of this literature review is to develop a model of methods used to influence prescribing. This article reviews well-controlled studies of educational efforts, describes and relates theories of human inference to these studies, and delineates a model...

Cite
Raisch DW. A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model. DICP. 1990;24(5):537-42doi: 10.1177/106002809002400514.
Raisch, D. W. (1990). A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model. DICP : the annals of pharmacotherapy, 24(5), 537-42. https://doi.org/10.1177/106002809002400514
Raisch, D W. "A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model." DICP : the annals of pharmacotherapy vol. 24,5 (1990): 537-42. doi: https://doi.org/10.1177/106002809002400514
Raisch DW. A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model. DICP. 1990 May;24(5):537-42. doi: 10.1177/106002809002400514. PMID: 2188440.
Copy Download .nbib Format: NLM
New FDA approvals: how to use them, when to suggest them.

RN

Rodman MJ.
PMID: 1546269
RN. 1992 Mar;55(3):58-65.

No abstract available.

Cite
Rodman MJ. New FDA approvals: how to use them, when to suggest them. RN. 1992;55(3):58-65
Rodman, M. J. (1992). New FDA approvals: how to use them, when to suggest them. RN, 55(3), 58-65.
Rodman, M J. "New FDA approvals: how to use them, when to suggest them." RN vol. 55,3 (1992): 58-65.
Rodman MJ. New FDA approvals: how to use them, when to suggest them. RN. 1992 Mar;55(3):58-65. PMID: 1546269.
Copy Download .nbib Format: NLM
Life after flow charting.

Nursing quality connection

Kreitzer MJ, Marko M.
PMID: 7767271
Nurs Qual Connect. 1994 Jul-Aug;4(1):8-9.

No abstract available.

Cite
Kreitzer MJ, Marko M. Life after flow charting. Nurs Qual Connect. 1994;4(1):8-9
Kreitzer, M. J., & Marko, M. (1994). Life after flow charting. Nursing quality connection, 4(1), 8-9.
Kreitzer, M J, and Marko, M. "Life after flow charting." Nursing quality connection vol. 4,1 (1994): 8-9.
Kreitzer MJ, Marko M. Life after flow charting. Nurs Qual Connect. 1994 Jul-Aug;4(1):8-9. PMID: 7767271.
Copy Download .nbib Format: NLM
Better therapies for children: a worldwide search for needed human resources.

Paediatric drugs

MacLeod SM.
PMID: 25956169
Paediatr Drugs. 2015 Jun;17(3):175-7. doi: 10.1007/s40272-015-0132-6.

A point has been reached in the pursuit of optimal prescribing for infants, children and youth where global deficiencies in inter-professional communication are presenting a substantial barrier to progress. In an effort to remedy this situation, the International Alliance...

Cite
MacLeod SM. Better therapies for children: a worldwide search for needed human resources. Paediatr Drugs. 2015;17(3):175-7doi: 10.1007/s40272-015-0132-6.
MacLeod, S. M. (2015). Better therapies for children: a worldwide search for needed human resources. Paediatric drugs, 17(3), 175-7. https://doi.org/10.1007/s40272-015-0132-6
MacLeod, Stuart M. "Better therapies for children: a worldwide search for needed human resources." Paediatric drugs vol. 17,3 (2015): 175-7. doi: https://doi.org/10.1007/s40272-015-0132-6
MacLeod SM. Better therapies for children: a worldwide search for needed human resources. Paediatr Drugs. 2015 Jun;17(3):175-7. doi: 10.1007/s40272-015-0132-6. PMID: 25956169.
Copy Download .nbib Format: NLM
["Recommended drugs" to provide safer treatment of children].

Lakartidningen

Cederblad F, Toss H, Hallberg P.
PMID: 24380163
Lakartidningen. 2013 Nov 13-19;110(46):2065.

No abstract available.

Cite
Cederblad F, Toss H, Hallberg P. "Rekommenderade läkemedel" ska ge säkrare behandling av barn. ["Recommended drugs" to provide safer treatment of children]. Lakartidningen. 2013;110(46):2065
Cederblad, F., Toss, H., & Hallberg, P. (2013). "Rekommenderade läkemedel" ska ge säkrare behandling av barn. ["Recommended drugs" to provide safer treatment of children]. Lakartidningen, 110(46), 2065.
Cederblad, Fredrik, et al. ""Rekommenderade läkemedel" ska ge säkrare behandling av barn." ["Recommended drugs" to provide safer treatment of children]. Lakartidningen vol. 110,46 (2013): 2065.
Cederblad F, Toss H, Hallberg P. "Rekommenderade läkemedel" ska ge säkrare behandling av barn. ["Recommended drugs" to provide safer treatment of children]. Lakartidningen. 2013 Nov 13-19;110(46):2065. Swedish. PMID: 24380163.
Copy Download .nbib Format: NLM
Science, drugs, and the Food and Drug Administration.

New York state journal of medicine

De Haen P.
PMID: 5284708
N Y State J Med. 1971 Jul 01;71(13):1644-50.

No abstract available.

Cite
De Haen P. Science, drugs, and the Food and Drug Administration. N Y State J Med. 1971;71(13):1644-50
De Haen, P. (1971). Science, drugs, and the Food and Drug Administration. New York state journal of medicine, 71(13), 1644-50.
De Haen, P. "Science, drugs, and the Food and Drug Administration." New York state journal of medicine vol. 71,13 (1971): 1644-50.
De Haen P. Science, drugs, and the Food and Drug Administration. N Y State J Med. 1971 Jul 01;71(13):1644-50. PMID: 5284708.
Copy Download .nbib Format: NLM
Necessity and requirements of bridging studies and their present status in Japan.

International journal of clinical pharmacology and therapeutics

Naito C.
PMID: 10706195
Int J Clin Pharmacol Ther. 2000 Feb;38(2):80-6. doi: 10.5414/cpp38080.

The mainstays of the harmonized final document about ethnic factors in the acceptability of foreign clinical data include a complete clinical data package and a bridging study (for efficacy and/or for safety). A clinical data package that meets all...

Cite
Naito C. Necessity and requirements of bridging studies and their present status in Japan. Int J Clin Pharmacol Ther. 2000;38(2):80-6doi: 10.5414/cpp38080.
Naito, C. (2000). Necessity and requirements of bridging studies and their present status in Japan. International journal of clinical pharmacology and therapeutics, 38(2), 80-6. https://doi.org/10.5414/cpp38080
Naito, C. "Necessity and requirements of bridging studies and their present status in Japan." International journal of clinical pharmacology and therapeutics vol. 38,2 (2000): 80-6. doi: https://doi.org/10.5414/cpp38080
Naito C. Necessity and requirements of bridging studies and their present status in Japan. Int J Clin Pharmacol Ther. 2000 Feb;38(2):80-6. doi: 10.5414/cpp38080. PMID: 10706195.
Copy Download .nbib Format: NLM
[Prescribe and advise freely].

Medecine tropicale : revue du Corps de sante colonial

[No authors listed]
PMID: 17286025
Med Trop (Mars). 2006 Dec;66(6):577-80.

Physicians know how totally unrealistic it is to expect drug companies to furnish reliable comparative information to assist therapeutic decision-making. All hope in this regard must be founded on personal effort to sort through available data and on independent...

Cite
Prescrire et conseiller en toute indépendance. [Prescribe and advise freely]. Med Trop (Mars). 2006;66(6):577-80
(2006). Prescrire et conseiller en toute indépendance. [Prescribe and advise freely]. Medecine tropicale : revue du Corps de sante colonial, 66(6), 577-80.
"Prescrire et conseiller en toute indépendance." [Prescribe and advise freely]. Medecine tropicale : revue du Corps de sante colonial vol. 66,6 (2006): 577-80.
Prescrire et conseiller en toute indépendance. [Prescribe and advise freely]. Med Trop (Mars). 2006 Dec;66(6):577-80. French. PMID: 17286025.
Copy Download .nbib Format: NLM
Ongoing education would boost competency in drug calculations.

Nursing times

Pryce-Miller M, Emanual V.
PMID: 20882823
Nurs Times. 2010 Aug 31-Sep 6;106(34):8.

No abstract available.

Cite
Pryce-Miller M, Emanual V. Ongoing education would boost competency in drug calculations. Nurs Times. 2010;106(34):8
Pryce-Miller, M., & Emanual, V. (2010). Ongoing education would boost competency in drug calculations. Nursing times, 106(34), 8.
Pryce-Miller, Maxine, and Emanual, Vernel. "Ongoing education would boost competency in drug calculations." Nursing times vol. 106,34 (2010): 8.
Pryce-Miller M, Emanual V. Ongoing education would boost competency in drug calculations. Nurs Times. 2010 Aug 31-Sep 6;106(34):8. PMID: 20882823.
Copy Download .nbib Format: NLM
Promoting more conservative prescribing.

JAMA

Schiff GD, Galanter WL.
PMID: 19244196
JAMA. 2009 Feb 25;301(8):865-7. doi: 10.1001/jama.2009.195.

No abstract available.

Cite
Schiff GD, Galanter WL. Promoting more conservative prescribing. JAMA. 2009;301(8):865-7doi: 10.1001/jama.2009.195.
Schiff, G. D., & Galanter, W. L. (2009). Promoting more conservative prescribing. JAMA, 301(8), 865-7. https://doi.org/10.1001/jama.2009.195
Schiff, Gordon D, and Galanter, William L. "Promoting more conservative prescribing." JAMA vol. 301,8 (2009): 865-7. doi: https://doi.org/10.1001/jama.2009.195
Schiff GD, Galanter WL. Promoting more conservative prescribing. JAMA. 2009 Feb 25;301(8):865-7. doi: 10.1001/jama.2009.195. PMID: 19244196.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries